| 英文别名 |
Ozagrel sodium;(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid sodium salt;OZAGREL SODIUM CP;Athrombone;Cataclot;Kadenin;OKY-046 sodium;Sodium ozagrel;Xanbon;XanbonS;Ozapen;D01684;Ozapen (tn);Ozagrel Impurity 2;Ozagrel sodium (jan);sodium (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;(E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylic acid sodium salt;Ozagrel sodium [WHO-DD];OKY-046 sodium;OKY 046 sodium;OKY046 sodium;F85114;EX-A5745;Sodium(E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate;HY-B0428A;2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1);4X5577N3ET;AMY3367;CCG-266963;AKOS015895382;2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (E)-;CS-3808;sodium 3-{4-[(1H-imidazol-1-yl)methyl]phenyl}prop-2-enoate;Sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;130952-46-4;AS-12150;KW-01;189224-26-8;DTXSID50172327;AKOS015967214;A912378;Ozagrel sodium (JP17);NCNYJCOBUTXCBR-IPZCTEOASA-M;Ozagrel sodium [JAN:WHO-DD];189224-26-8 (sodium);Q27260625;BCP12393;UNII-4X5577N3ET;Ozagrel sodium salt [MI];2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt (1:1), (2E)-;AKOS025149474;Ozagrel (sodium);2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (2E)-;AC-15516;SCHEMBL3093220;Ozagrel sodium [JAN];HMS3887A15;Monosodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoate;Ozagrel sodium (JP18);Monosodium (2E)-3-(4-(1H-imidazol-1-ylmethyl)phenyl)prop-2-enoate;2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt,(2E)-;OZAGREL SODIUM SALT;DTXCID5094818 |
